V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230002334 | 230008383 | 1.58 | 75 | null | 2020-11-19 | 2020-11-26 | Niraparib | 02 | null | NIRAPARIB | 100612079 |
| 230002335 | 230008384 | 1.57 | 59.8 | Palliative (P) | 2016-10-29 | 2017-04-23 | Liposomal Doxorubicin 40mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 101572000 |
| 230002336 | 230008385 | 1.66 | 57.4 | null | 2017-10-11 | 2017-11-01 | null | null | null | PEMBROLIZUMAB | 100995690 |
| 230002337 | 230008386 | null | null | null | 2019-10-27 | 2019-10-27 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100935145 |
| 230002338 | 230008387 | 1.69 | 62.8 | null | 2019-10-01 | 2019-10-02 | Niraparib | 02 | null | NIRAPARIB | 100508491 |
| 230002340 | 230008388 | 1.64 | 61.6 | null | 2021-11-25 | 2021-11-27 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101496886 |
| 230002345 | 230008391 | 0 | 61.7 | null | 2021-06-15 | 2021-06-18 | Liposomal Doxorubicin 50mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 100861950 |
| 230002349 | 230008393 | 1.58 | 84.45 | null | null | 2019-12-03 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100379957 |
| 230002354 | 230008394 | 1.62 | 67.5 | null | 2021-06-21 | 2021-07-12 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101815667 |
| 230002359 | 230008396 | 1.48 | 106.2 | null | 2019-09-10 | 2019-10-04 | Olaparib | 02 | null | OLAPARIB | 101386716 |
| 230002362 | 230008398 | 1.55 | 97 | Palliative (P) | 2021-01-01 | 2021-07-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100665034 |
| 230002364 | 230008400 | 1.61 | 51.5 | Palliative (P) | null | 2020-12-24 | PACLITAXEL | 02 | N | PACLITAXEL | 100896076 |
| 230002367 | 230008401 | 1.62 | 86.9 | Adjuvant (A) | null | 2020-07-23 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100717441 |
| 230002368 | 230008402 | 1.56 | 101 | null | 2019-10-05 | 2019-10-11 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100273349 |
| 230002372 | 230008404 | null | 57.6 | Neo-adjuvant (N) | 2020-11-29 | 2020-12-18 | Rucaparib | 02 | N | RUCAPARIB | 100562230 |
| 230002373 | 230008405 | null | null | Palliative (P) | 2020-03-09 | 2020-03-27 | Niraparib | 02 | N | NIRAPARIB | 101325375 |
| 230002384 | 230008407 | null | null | null | 2019-06-07 | 2019-06-14 | PACLITAXEL | 02 | null | PACLITAXEL | 100492678 |
| 230002389 | 230008409 | 1.56 | 68 | null | 2017-05-01 | 2017-10-20 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101327063 |
| 230002391 | 230008411 | 1.68 | 93.9 | null | 2016-03-06 | 2016-03-11 | Trial Unspecified | 02 | null | CISPLATIN | 101703031 |
| 230002392 | 230008412 | 1.68 | 156.1 | null | 2020-04-22 | 2020-09-25 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101145028 |
| 230002394 | 230008413 | 1.63 | 70.8 | null | 2018-09-10 | 2018-09-19 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100074082 |
| 230002396 | 230008414 | 1.64 | 98.7 | null | null | 2018-08-10 | Rucaparib | 02 | null | RUCAPARIB | 100908412 |
| 230002397 | 230008415 | 1.6 | 76.9 | null | 2020-06-18 | 2020-12-15 | Liposomal Doxorubicin 40mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 100077095 |
| 230002398 | 230008416 | 1.59 | 70.3 | null | 2019-02-27 | 2019-02-27 | Niraparib | 02 | null | NIRAPARIB | 101454778 |
| 230002401 | 230008417 | 1.63 | 60.8 | Palliative (P) | 2020-09-03 | 2021-01-01 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100698941 |
| 230002402 | 230008418 | null | null | null | 2020-02-17 | 2020-02-23 | CARBOPLATIN + GEMCITABINE | 02 | null | CISPLATIN | 100543219 |
| 230002407 | 230008420 | 1.55 | 0 | null | 2020-05-26 | 2020-06-13 | null | 02 | null | CVP R | 101372873 |
| 230002410 | 230008422 | 1.6 | 77.5 | null | 2019-03-13 | 2019-12-10 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100477175 |
| 230002411 | 230008423 | 1.48 | 63.7 | null | 2022-02-04 | 2022-02-04 | null | null | null | DOXORUBICIN | 101215995 |
| 230002412 | 230008424 | 1.63 | 83.8 | null | null | 2016-08-29 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101528187 |
| 230002416 | 230008425 | 1.5 | 80 | Neo-adjuvant (N) | 2019-07-28 | 2019-11-23 | Carboplatin + Liposomal Doxorubicin | 02 | Y | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100430655 |
| 230002418 | 230008427 | 1.51 | 58.1 | Palliative (P) | 2020-03-25 | 2020-04-01 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101513177 |
| 230002419 | 230008428 | 1.47 | 56.3 | Palliative (P) | 2020-08-10 | 2021-06-16 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101415491 |
| 230002420 | 230008429 | 1.68 | 88.3 | null | 2019-04-13 | 2019-04-15 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101530881 |
| 230002422 | 230008430 | 1.53 | 80.2 | null | null | 2019-11-13 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101577502 |
| 230002424 | 230008431 | 1.61 | 50.4 | null | 2021-02-02 | 2021-02-03 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100346889 |
| 230002426 | 230008432 | 1.68 | 84.9 | null | 2019-11-05 | 2019-11-20 | null | 02 | null | GEMCITABINE | 100842547 |
| 230002430 | 230008433 | null | null | null | 2020-01-07 | 2021-11-04 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 101688027 |
| 230002440 | 230008437 | 1.53 | 87 | Neo-adjuvant (N) | 2019-06-29 | 2021-12-31 | null | null | N | OLAPARIB | 101374666 |
| 230002441 | 230008438 | 1.55 | 73.1 | Palliative (P) | null | 2019-11-21 | Niraparib | 02 | N | NIRAPARIB | 101575493 |
| 230002448 | 230008440 | null | null | Palliative (P) | 2017-10-18 | 2017-10-20 | null | 02 | N | TRIAL UNSPECIFIED | 100086999 |
| 230002455 | 230008442 | 1.53 | 45.2 | null | 2021-08-20 | 2021-08-25 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100663024 |
| 230002457 | 230008444 | null | null | null | 2020-03-14 | 2020-07-19 | Bevacizumab | 02 | null | BEVACIZUMAB | 100471205 |
| 230002459 | 230008445 | null | null | Curative (C) | 2017-07-29 | 2017-08-05 | Bevacizumab+Carbo+Pacliaxel | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101538659 |
| 230002461 | 230008447 | 1.57 | 78.7 | null | 2019-12-18 | 2020-01-08 | Bevacizumab | 02 | null | BEVACIZUMAB | 101744962 |
| 230002466 | 230008451 | 1.63 | 70.3 | null | 2017-12-17 | 2017-12-30 | null | null | null | LIPOSOMAL DOXORUBICIN | 101067349 |
| 230002467 | 230008452 | 1.61 | 82.7 | null | null | 2021-07-15 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101109514 |
| 230002469 | 230008453 | 1.66 | 49 | null | 2016-08-01 | 2016-08-01 | null | null | null | CISPLATIN | 100253053 |
| 230002470 | 230008454 | null | null | null | 2019-01-29 | 2019-06-25 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100266774 |
| 230002471 | 230008455 | null | null | null | 2019-06-10 | 2021-05-22 | GemCarbo Days 1+8 | 02 | null | TRIAL UNSPECIFIED | 100067205 |